Clinical commissioning of intensity-modulated proton therapy systems: Report of AAPM Task Group 185.
IMPT
PBS
calibration
commissioning
modulated scanning
proton
scanning
Journal
Medical physics
ISSN: 2473-4209
Titre abrégé: Med Phys
Pays: United States
ID NLM: 0425746
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
10
02
2020
revised:
17
08
2020
accepted:
18
08
2020
pubmed:
21
10
2020
medline:
1
5
2021
entrez:
20
10
2020
Statut:
ppublish
Résumé
Proton therapy is an expanding radiotherapy modality in the United States and worldwide. With the number of proton therapy centers treating patients increasing, so does the need for consistent, high-quality clinical commissioning practices. Clinical commissioning encompasses the entire proton therapy system's multiple components, including the treatment delivery system, the patient positioning system, and the image-guided radiotherapy components. Also included in the commissioning process are the x-ray computed tomography scanner calibration for proton stopping power, the radiotherapy treatment planning system, and corresponding portions of the treatment management system. This commissioning report focuses exclusively on intensity-modulated scanning systems, presenting details of how to perform the commissioning of the proton therapy and ancillary systems, including the required proton beam measurements, treatment planning system dose modeling, and the equipment needed.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1-e30Informations de copyright
© 2020 American Association of Physicists in Medicine.
Références
Mohan R, Paganetti H. Appendix: nomenclature and terminology in proton therapy. In: Das I, Paganetti H, ed. Principles and Practice of Proton Beam Therapy. Madison, WI: Medical Physics Publishing, Inc.; 2015:819-828.
Arjomandy B, Taylor P, Ainsley C, et al. Report of the AAPM Task Group 224: Proton Machine QA. College Park, MD: American Association of Physicists in Medicine; 2017.
Piersimoni P, Rimoldi A, Riccardi C, Pirola M, Molinelli S, Ciocca M. Optimization of a general-purpose, actively scanned proton beamline for ocular treatments: Geant4 simulations. J Appl Clin Med Phys. 2015;16:5227.
Farr JB, Moskvin V, Lukose RC, Tuomanen S, Tsiamas P, Yao W. Development, commissioning, and evaluation of a new intensity modulated minibeam proton therapy system. Med Phys. 2018;45(9):4227-4237. https://doi.org/10.1002/mp.13093
Paganetti H, Blakely E, Carabe-Fernandez A, et al. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019;46:e53-e78.
Ciangaru G, Yang JN, Oliver PJ, et al. Verification procedure for isocentric alignment of proton beams. J Appl Clin Med Phys. 2007;8:65-75.
Farr JB, Dessy F, De Wilde O, Bietzer O, Schonenberg D. Fundamental radiological and geometric performance of two types of proton beam modulated discrete scanning systems. Med Phys. 2013;40:072101.
Smith A, Gillin M, Bues M, et al. The M. D. Anderson proton therapy system. Med Phys. 2009;36:4068-4083.
Farr JB, Kruse JJ. Acceptance testing. In: Das I, Paganetti H, ed. Principles and Practice of Proton Beam Therapy. Madison, WI: Medical Physics Publishing, Inc.; 2015:353-403.
Thomadsen B, Nath R, Bateman FB, et al. Potential hazard due to Induced radioactivity secondary to radiotherapy: the report of Task Group 136 of the American Association of Physicists in Medicine. Health Phys. 2014;107:442-460.
American College of Radiology (ACR). ACR-AAPM Technical standard for the performance of proton beam radiation therapy. Reston, VA; 2018.
Farr JB, Flanz JB, Gerbershagen A, Moyers MF. New horizons in particle therapy systems. Med Phys. 2018;45:e953-e983.
Farr JB, Maughan RL. Dosimetry for proton and carbon ion therapy. In: Ma C-M, Lomax AJ, eds. Proton and Carbon Ion Therapy. Boca Raton: CRC Press; 2013.
Palmans H. Dosimetry. In: Paganetti H, ed. Proton Therapy Physics. Boca Raton: CRC Press; 2013.
International Electrotechnical Commission (IEC). ISO: 14253-1:2013: Geometrical product specifications. Geneva; 2013.
International Electrotechnical Commission (IEC). Medical electrical equipment - Particular requirements for the basic safety and essential performance of light ion beam medical electrical equipment. Geneva; 2014.
Das IJ, Paganetti H. Principles and Practice of Proton Beam Therapy. Madison, WI: Medical Physics Publishing, Inc.; 2015.
Vatnitsky AS, Moyers MF. Practical Implementation of Light Ion Beam Treatments. Madison: Medical Physics Publishing; 2013.
Paganetti H. Proton Therapy Physics, 2nd edn. Boca Raton: CRC Press; 2018.
Ma C-M, Lomax AJ. Proton and Carbon Ion Therapy. Boca Raton: CRC Press; 2013.
Andreo B, Hohlfeld H, Kanai L, Smyth V. Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water (Technical Report Series 398); 2004, Vienna.
Martisikova M, Jäkel O. Gafchromic (R) EBT films for ion dosimetry. Radiat Measur. 2010;45:1268-1270.
Mumot M, Mytsin GV, Molokanov AG, Malicki J. The comparison of doses measured by radiochromic films and semiconductor detector in a 175MeV proton beam. Phys Med. 2009;25:105-110.
Reinhardt S, Hillbrand M, Wilkens JJ, Assmann W. Comparison of Gafchromic EBT2 and EBT3 films for clinical photon and proton beams. Med Phys. 2012;39:5257-5262.
Niroomand-Rad A, Blackwell CR, Coursey BM, et al. Radiochromic film dosimetry: recommendations of AAPM Radiation Therapy Committee Task Group 55. American Association of Physicists in Medicine. Med Phys. 1998;25:2093-2115.
Vatnitsky SM. Radiochromic film dosimetry for clinical proton beams. Appl Radiat Isot. 1997;48:643-651.
Newhauser W, Fontenot J, Zheng YS, et al. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm. Phys Med Biol. 2007;52:4569-4584.
Khatonabadi M, Zhang D, Mathieu K, et al. A comparison of methods to estimate organ doses in CT when utilizing approximations to the tube current modulation function. Med Phys. 2012;39:5212-5228.
Tian X, Li X, Segars WP, Frush DP, Samei E. Prospective estimation of organ dose in CT under tube current modulation. Med Phys. 2015;42:1575-1585.
Khatonabadi M, Kim HJ, Lu P, et al. The feasibility of a regional CTDI volume to estimate organ dose from tube current modulated CT exams. Med Phys. 2013;40:1-11.
Moore BM, Brady SL, Mirro AE, Kaufman RA. Size-specific dose estimate (SSDE) provides a simple method to calculate organ dose for pediatric CT examinations. Med Phys. 2014;41:1-9.
Turner AC, Zhang D, Khatonabadi M, et al. The feasibility of patient size-corrected, scanner-independent organ dose estimates for abdominal CT exams. Med Phys. 2011;38:820-829.
McCollough CH, Bakalyar DM, Bostani M, et al. Use of water equivalent diameter for calculating patient size and size-specific dose estimates (SSDE) in CT: report of AAPM Task Group 220. AAPM Rep. 2014;2014:6-23.
Moyers MF, Toth T, Sadagopan R, et al. Report No. 202 - Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments. American Association of Physicists in Medicine; 2020.
Moyers MF, Sardesai M, Sun S, Miller DW. Ion stopping powers and CT numbers. Med Dosim. 2010;35:179-194.
Fippel M, Soukup M. A Monte Carlo dose calculation algorithm for proton therapy. Med Phys. 2004;31:2263-2273.
Schneider W, Bortfeld T, Schlegel W. Correlation between CT numbers and tissue parameters needed for Monte Carlo simulations of clinical dose distributions. Phys Med Biol. 2000;45:459-478.
Jiang HY, Seco J, Paganetti H. Effects of Hounsfield number conversion on CT based proton Monte Carlo dose calculations. Med Phys. 2007;34:1439-1449.
Kanematsu N, Matsufuji N, Kohno R, Minohara S, Kanai T. A CT calibration method based on the polybinary tissue model for radiotherapy treatment planning. Phys Med Biol. 2003;48:1053-1064.
Jiang H, Paganetti H. Adaptation of GEANT4 to Monte Carlo dose calculations based on CT data. Med Phys. 2004;31:2811-2818.
Battista JJ, Meeker B, Chapman D, Castor W. Animal tumor volume and density by CT. J Comput Assisted Tomogr. 1980;4:714.
Sontag MR, Battista JJ, Bronskill MJ, Cunningham JR. Implications of computed tomography for inhomogeneity corrections in photon beam dose calculations. Radiology. 1977;124(1):143-149.
Chen GTY. Quantitative CT in charged-particle radiotherapy. J Comput Assisted Tomogr. 1979;3:861-862.
Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol. 1996;41:111-124.
Schaffner B, Pedroni E. The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power. Phys Med Biol. 1998;43:1579-1592.
Moyers M, Sun S, Sardesai M, et al. Tornotherapy MVXCT numbers versus RLSP for various ions and materials. Med Phys. 2007;34:2383.
Moyers MF. Comparison of x ray computed tomography number to proton relative linear stopping power conversion functions using a standard phantom. Med Phys. 2014;41:061705.
Taylor P, Lowenstein J, Kry S, Ibbott G, Followill D. A comparison of CT number to relative linear stopping power conversion curves used by proton therapy centers. Med Phys. 2015;42:3616.
Grant RL, Summers PA, Neihart JL, et al. Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy. J Appl Clin Med Phys. 2014;15:121-126.
Saito M. Spectral optimization for measuring electron density by the dual-energy computed tomography coupled with balanced filter method. Med Phys. 2009;36:3631-3642.
Bourque AE, Carrier JF, Bouchard H. A stoichiometric calibration method for dual energy computed tomography. Phys Med Biol. 2014;59:2059-2088.
Yang M, Virshup G, Clayton J, Zhu XR, Mohan R, Dong L. Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissues. Phys Med Biol. 2010;55:1343-1362.
Han D, Siebers JV, Williamson JF. A linear, separable two-parameter model for dual energy CT imaging of proton stopping power computation. Med Phys. 2016;43:600-612.
Hünemohr N, Krauss B, Dinkel J, et al. Ion range estimation by using dual energy computed tomography. Z Med Phys. 2013;23:300-313.
Hünemohr N, Krauss B, Tremmel C, Ackermann B, Jakel O, Greilich S. Experimental verification of ion stopping power prediction from dual energy CT data in tissue surrogates. Phys Med Biol. 2014;59:83-96.
Yang M, Zhu XR, Park PC, et al. Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration. Phys Med Biol. 2012;57:4095-4115.
Liebl J, Paganetti H, Zhu M, Winey BA. The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions. Med Phys. 2014;41:091711.
Park PC, Cheung JP, Zhu XR, et al. Statistical assessment of proton treatment plans under setup and range uncertainties. Int J Radiat Oncol Biol Phys. 2013;86:1007-1013.
Kruse JJ. Immobilization and simulation. In: Das I, Paganetti H, eds. Principles and Practice of Proton Beam Therapy. Madison, WI: Medical Physics Publishing, Inc.; 2015:521-537.
Wroe AJ, Bush DA, Schulte RW, Slater JD. Clinical immobilization techniques for proton therapy. Technol Cancer Res Treat. 2015;14:71-79.
Wroe AJ, Bush DA, Slater JD. Immobilization considerations for proton radiation therapy. Technol Cancer Res Treat. 2014;13:217-226.
Wroe AJ, Ghebremedhin A, Gordon IR, Schulte RW, Slater JD. Water equivalent thickness analysis of immobilization devices for clinical implementation in proton therapy. Technol Cancer Res Treat. 2014;13:415-420.
Olch AJ, Gerig L, Li H, Mihaylov I, Morgan A. Dosimetric effects caused by couch tops and immobilization devices: report of AAPM Task Group 176. Med Phys. 2014;41.061501-1-061501-30.
Kim JS, Yoon M, Ahn S, et al. Modeling of a digital couch for a proton treatment planning system. J Korean Phys Soc. 2009;55:1640-1648.
Zhang R, Taddei PJ, Fitzek MM, Newhauser WD. Water equivalent thickness values of materials used in beams of protons, helium, carbon and iron ions. Phys Med Biol. 2010;55:2481-2493.
Zhang R, Newhauser WD. Calculation of water equivalent thickness of materials of arbitrary density, elemental composition and thickness in proton beam irradiation. Phys Med Biol. 2009;54:1383-1395.
Tatsuzaki H, Urie MM. Importance of precise positioning for proton beam therapy in the base of skull and cervical spine. Int J Radiat Oncol Biol Phys. 1991;21:757-765.
Fellin F, Righetto R, Fava G, Trevisan D, Amelio D, Farace P. Water equivalent thickness of immobilization devices in proton therapy planning - modelling at treatment planning and validation by measurements with a multi-layer ionization chamber. Phys Med. 2017;35:31-38.
Vargas C, Mahajan C, Fryer A, et al. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007;69:1110-1116.
Hedrick SG, Fagundes M, Robison B, et al. A comparison between hydrogel spacer and endorectal balloon: an analysis of intrafraction prostate motion during proton therapy. J Appl Clin Med Phys. 2017;18:106-112.
Newhauser WD, Giebeler A, Langen KM, Mirkovic D, Mohan R. Can megavoltage computed tomography reduce proton range uncertainties in treatment plans for patients with large metal implants? Phys Med Biol. 2008;53:2327-2344.
Wei JK, Sandison GA, Hsi WC, Ringor M, Lu XY. Dosimetric impact of a CT metal artefact suppression algorithm for proton, electron and photon therapies. Phys Med Biol. 2006;51:5183-5197.
Lee KYG, Cheng HMJ, Chu CY, Tam CWA, Kan WK. Metal artifact reduction by monoenergetic extrapolation of dual-energy CT in patients with metallic implants. J Orthop Surg (Hong Kong). 2019;27:2309499019851176.
Liao E, Srinivasan A. Applications of dual-energy computed tomography for artifact reduction in the head, neck, and spine. Neuroimaging Clin N Am. 2017;27:489-497.
Nair JR, DeBlois F, Ong T, et al. Dual-energy CT: balance between iodine attenuation and artifact reduction for the evaluation of head and neck cancer. J Comput Assist Tomogr. 2017;41:931-936.
Paudel MR, Mackenzie M, Fallone BG, Rathee S. Evaluation of normalized metal artifact reduction (NMAR) in kVCT using MVCT prior images for radiotherapy treatment planning. Med Phys. 2013;40:081701.
Pessis E, Sverzut JM, Campagna R, Guerini H, Feydy A, Drape JL. Reduction of metal artifact with dual-energy CT: virtual monospectral imaging with fast kilovoltage switching and metal artifact reduction software. Semin Musculoskelet Radiol. 2015;19:446-455.
Landry G, Hua CH. Current state and future applications of radiological image guidance for particle therapy. Med Phys. 2018;45:e1086-e1095.
Koehler AM. Proton radiography. Science. 1968;160:303-304.
Koehler AM. Proton radiography. Phys Med Biol. 1970;15:181.
Schneider U, Pedroni E. Proton radiography as a tool for quality-control in proton therapy. Med Phys. 1995;22:353-363.
Pemler P, Besserer J, de Boer J, et al. A detector system for proton radiography on the gantry of the Paul-Scherrer-Institute. Nucl Instrum Meth A. 1999;432:483-495.
Sadrozinski HFW, Bashkirov V, Bruzzi M, et al. Issues in proton computed tomography. Nucl Instrum Meth A. 2003;511:275-281.
Sadrozinski HFW, Bashkirov V, Keeney B, et al. Toward proton computed tomography. IEEE Trans Nucl Sci. 2004;51:3-9.
Schneider U, Besserer J, Pemler P, et al. First proton radiography of an animal patient. Med Phys. 2004;31:1046-1051.
de Assis JT, Yevseyeva O, Evseev I, et al. Proton computed tomography as a tool for proton therapy planning: preliminary computer simulations and comparisons with x-ray CT basics. X-Ray Spectrom. 2005;34:481-492.
Schulte RW, Bashkirov V, Klock MCL, et al. Density resolution of proton computed tomography. Med Phys. 2005;32:1035-1046.
Talamonti C, Reggioli V, Bruzzi M, et al. Proton radiography for clinical applications. Nucl Instrum Meth A. 2010;612:571-575.
Esposito M, Waltham C, Taylor JT, et al. PRaVDA: the first solid-state system for proton computed tomography. Phys Med. 2018;55:149-154.
Schulte RW, Bashkirov V, Johnson R, Sadrozinski HF, Schubert KE. Overview of the LLUMC/UCSC/CSUSB phase 2 proton CT project. Trans Am Nucl Soc. 2012;106:59-62.
Knecht ML, Wang N, Vassantachart A, Mifflin R, Slater JD, Yang GY. Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors. J Gastrointest Oncol. 2017;8:675-682.
Xie Y, Bentefour EH, Janssens G, et al. Prompt Gamma imaging for in vivo range verification of pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys. 2017;99:210-218.
Richter C, Pausch G, Barczyk S, et al. First clinical application of a prompt gamma based in vivo proton range verification system. Radiother Oncol. 2016;118:232-237.
Hueso-Gonzalez F, Fiedler F, Golnik C, et al. Compton camera and prompt gamma ray timing: two methods for in vivo range assessment in proton therapy. Front Oncol. 2016;6:80.
Verburg JM, Testa M, Seco J. Range verification of passively scattered proton beams using prompt gamma-ray detection. Phys Med Biol. 2015;60:1019-1029.
Polf JC, Avery S, Mackin DS, Beddar S. Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification. Phys Med Biol. 2015;60:7085-7099.
Verburg JM, Seco J. Proton range verification through prompt gamma-ray spectroscopy. Phys Med Biol. 2014;59:7089-7106.
Polf JC, Mackin D, Lee E, Avery S, Beddar S. Detecting prompt gamma emission during proton therapy: the effects of detector size and distance from the patient. Phys Med Biol. 2014;59:2325-2340.
Golnik C, Hueso-Gonzalez F, Muller A, et al. Range assessment in particle therapy based on prompt gamma-ray timing measurements. Phys Med Biol. 2014;59:5399-5422.
Verburg JM, Riley K, Bortfeld T, Seco J. Energy- and time-resolved detection of prompt gamma-rays for proton range verification. Phys Med Biol. 2013;58:L37-L49.
Combs SE, Bauer J, Unholtz D, et al. Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study. BMC Cancer. 2012;12:133.
Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys. 2009;36:4136-4146.
Meissner H, Fuchs H, Hirtl A, Reschl C, Stock M. Towards offline PET monitoring of proton therapy at MedAustron. Z Med Phys. 2019;29:59-65.
Moteabbed M, Espana S, Paganetti H. Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy. Phys Med Biol. 2011;56:1063-1082.
Nishio T, Ogino T, Nomura K, Uchida H. Dose-volume delivery guided proton therapy using beam on-line PET system. Med Phys. 2006;33:4190-4197.
Oelfke U, Lam GK, Atkins MS. Proton dose monitoring with PET: quantitative studies in Lucite. Phys Med Biol. 1996;41:177-196.
Parodi K, Bortfeld T, Enghardt W, et al. PET imaging for treatment verification of ion therapy: Implementation and experience at GSI Darmstadt and MGH Boston. Nucl Instrum Meth A. 2008;591:282-286.
Parodi K, Enghardt W. Potential application of PET in quality assurance of proton therapy. Phys Med Biol. 2000;45:N151-N156.
Zhu XP, Espana S, Daartz J, et al. Monitoring proton radiation therapy with in-room PET imaging. Phys Med Biol. 2011;56:4041-4057.
Yoon M, Cheong M, Kim J, Shin DH, Park SY, Lee SB. Accuracy of an automatic patient-positioning system based on the correlation of two edge images in radiotherapy. J Digit Imaging. 2011;24:322-330.
Bennett KF, Ruther H, Vandervlugt G, Yates ADB. Patient positioning for proton therapy at the National-Accelerator-Center. S Afr J Sci. 1994;90:370-371.
Devicienti S, Strigari L, D'Andrea M, Benassi M, Dimiccoli V, Portaluri M. Patient positioning in the proton radiotherapy era. J Exp Clin Canc Res. 2010;29:47.
Grusell E, Montelius A, Russell KR, et al. Patient positioning for fractionated precision radiation treatment of targets in the head using fiducial markers. Radiother Oncol. 1994;33:68-72.
Habermehl D, Henkner K, Ecker S, Jäkel O, Debus J, Combs SE. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy. J Radiat Res. 2013;54:61-68.
Matsuura T, Maeda K, Sutherland K, et al. Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: A simulation study. Med Phys. 2012;39:5584-5591.
Newhauser W, Fontenot J, Koch N, et al. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate. Phys Med Biol. 2007;52:2937-2952.
Newhauser WD, Koch NC, Fontenot JD, et al. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy. Phys Med Biol. 2007;52:3979-3990.
Ramirez E, Zheng Y, Rana S. SU-E-J-33: proton therapy fiducial comparison. Med Phys. 2013;40:157.
Klein EE, Hanley J, Bayouth J, et al. Task Group 142 report: Quality assurance of medical accelerators. Med Phys. 2009;36:4197-4212.
Yin F, Wong J, et al. Report No. 104: the role of in-room kV x-ray imaging for patient setup and target localization. American Association of Physicists in Medicine; 2009.
Arjomandy B, Sahoo N, Zhu XR, et al. An overview of the comprehensive proton therapy machine quality assurance procedures implemented at The University of Texas M. D. Anderson Cancer Center Proton Therapy Center-Houston. Med Phys. 2009;36:2269-2282.
Newhauser WD, Hunjan S. Quality assurance of proton therapy. In: Pawlicki T, Dunscombe P, Mundt AJ, Scalliet P, ed. Quality and Safety in Radiotherapy. Boca Raton: CRC Press; 2011.
Zhang XD, Dong L, Lee AK, et al. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2007;67:620-629.
Landry G, Dedes G, Zollner C, et al. Phantom based evaluation of CT to CBCT image registration for proton therapy dose recalculation. Phys Med Biol. 2015;60:595-613.
Landry G, Nijhuis R, Dedes G, et al. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation. Med Phys. 2015;42:1354-1366.
Chen WJ, Gemmel A, Rietzel E. A patient-specific planning target volume used in 'plan of the day' adaptation for interfractional motion mitigation. J Radiat Res. 2013;54:82-90.
Dong L, Cheung JP, Zhu XR. Image-guided proton and carbon ion therapy. In: Ma L, ed. Proton and Carbon Ion Therapy. Boca Raton: CRC Press; 2013.
Bolsi A, Lomax AJ, Pedroni E, Goitein G, Hug E. Experiences at the Paul Scherrer Institute with a remote patient positioning procedure for high-throughput proton radiation therapy. Int J Radiat Oncol Biol Phys. 2008;71:1581-1590.
Bissonnette JP, Balter PA, Dong L, et al. Quality assurance for image-guided radiation therapy utilizing CT-based technologies: a report of the AAPM TG-179. Med Phys. 2012;39:1946-1963.
Siochi RA, Balter P, Bloch CD, et al. Information technology resource management in radiation oncology. J Appl Clin Med Phys. 2009;10:16-35.
Digital Imaging and Communications in Medicine (DICOM). Supplement 11: Radiotherapy Objects; 1997.
Digital Imaging and Communications in Medicine (DICOM). Supplement 102: Radiotherapy Extensions for Ion Therapy; 2006.
Swerdloff SJ. Data handling in radiation therapy in the age of image-guided radiation therapy. Semin Radiat Oncol. 2007;17:287-292.
Bosch W, Curran B, Swerdloff S. IHE-RO: interoperable data standards for radiation oncology. In: Proceedings of the XVIth International Conference on the Use of Computers in Radiation Therapy (ICCR 2010), Amsterdam, The Netherlands. June 3, 2010; 2010.
Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407-421.
International Commission on Radiation Units & Measurements. Prescribing, Recording, and Reporting Proton-Beam Therapy (Report No. 78). Washington, DC: International Commission on Radiation Units and Measurements, Inc.;(2007). 78: Prescibing, Recording, and Reporting Proton-Beam Therapy.
Farr JB, Maughan RL. Dosimetry for proton and carbon ion therapy. In: Ma C-M, Lomax A, eds. Proton and Carbon Ion Therapy. Boca Raton: CRC Press; 2012:99-126.
Vynckier S. Dosimetry of clinical neutron and proton beams: an overview of recommendations. Radiat Prot Dosimet. 2004;110:565-572.
Andreo P, Burns D, Hohlfeld K, et al. TRS-398: Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water (Technical Report Series 398). International Atomic Energy Agency, Vienna; 2001:420.
Brede HJ, Greif KD, Hecker O, et al. Absorbed dose to water determination with ionization chamber dosimetry and calorimetry in restricted neutron, photon, proton and heavy-ion radiation fields. Phys Med Biol. 2006;51:3667-3682.
Delacroix S, Bridier A, Mazal A, et al. Proton dosimetry comparison involving ionometry and calorimetry. Int J Radiat Oncol Biol Phys. 1997;37:711-718.
Medin J. Implementation of water calorimetry in a 180 MeV scanned pulsed proton beam including an experimental determination of k(Q) for a Farmer chamber. Phys Med Biol. 2010;55:3287-3298.
Palmans H, Seuntjens J, Verhaegen F, Denis JM, Vynckier S, Thierens H. Water calorimetry and ionization chamber dosimetry in an 85-MeV clinical proton beam. Med Phys. 1996;23:643-650.
Sarfehnia A, Clasie B, Chung E, et al. Direct absorbed dose to water determination based on water calorimetry in scanning proton beam delivery. Med Phys. 2010;37:3541-3550.
Jin H, Chen Y, Kendall E, Ahmad S. Commissioning of the compact pencil beam scanning proton beam therapy system. JACMP. 2019;19:94-105.
Muir BR, Cojocaru CD, McEwen MR, Ross CK. Electron beam water calorimetry measurements to obtain beam quality conversion factors. Med Phys. 2017;44:5433-5444.
Gomà C, Hofstetter-Boillat B, Safai S, Vörös S. Experimental validation of beam quality correction factors for proton beams. Phys Med Biol. 2015;60:3207-3216.
Medin J. Implementation of water calorimetry in a 180 MeV scanned pulsed proton beam including an experimental determination of kQ for a Farmer chamber. Phys Med Biol. 2010;55:3287-3298.
Lin L, Kang M, Solberg TD, et al. Use of a novel two-dimensional ionization chamber array for pencil beam scanning proton therapy beam quality assurance. J Appl Clin Med Phys. 2015;16:5323.
Seco J, Clasie B, Partridge M. Review on the characteristics of radiation detectors for dosimetry and imaging. Phys Med Biol. 2014;59:R303-R347.
Moyers MF, Vatnitsky SM. Radiation therapy with light ions. In: van Dyk J, ed. The Modern Technology of Radiation Oncology: A Compendium for Medical Physicists and Radiation Oncologists, 3rd edn. Madison, Wisconsin: Medical Physics Publishing; 2013:183-222.
Boag JW, Currant J. Current collection and ionic recombination in small cylindrical ionization chambers exposed to pulsed radiation. Br J Radiol. 1980;53:471-478.
Rossomme S, Delor A, Lorentini S, et al. Three-voltage linear method to determine ion recombination in proton and light-ion beams. Phys Med Biol. 2020;65:045015.
Liszka M, Stolarczyk L, Klodowska M, et al. Ion recombination and polarity correction factors for a plane-parallel ionization chamber in a proton scanning beam. Med Phys. 2018;45:391-401.
Mirandola A, Magro G, Maestri D, et al. Determination of ion recombination and polarity effect correction factors for a plane-parallel ionization Bragg peak chamber under proton and carbon ion pencil beams. Phys Med Biol. 2019;64:095010.
Vatnitsky S, Moyers M, Miller D, et al. Proton dosimetry inter-comparison based on the ICRU report 59 protocol. Radiother Oncol. 1999;51:273-279.
Farr JB, Mascia AE, Hsi WC, et al. Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking. Med Phys. 2008;35:4945-4954.
Nichiporov D, Kostjuchenko V, Puhl JM, et al. Investigation of applicability of alanine and radiochromic detectors to dosimetry of proton clinical beams. Appl Radiat Isot. 1995;46:1355-1362.
Summers P, Ibbott GS, Moyers MF, Grant RL, Followill DS. Comparison of clinical parameters for proton therapy in the United States. Int J Radiat Oncol Biol Phys. 2012;84:S30.
Newhauser WD, Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 2011;11:438-448.
Ardenfors O, Dasu A, Lillhok J, Persson L, Gudowska I. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment. Phys Med. 2018;53:129-136.
Brodin NP, Munck Af Rosenschold P, Aznar MC, et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol. 2011;50:806-816.
Fontenot JD, Lee AK, Newhauser WD. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74:616-622.
Fuji H, Schneider U, Ishida Y, et al. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas. Radiat Oncol. 2013;8:255.
Paganetti H, Depauw N, Johnson A, Forman RB, Lau J, Jimenez R. The risk for developing a secondary cancer after breast radiation therapy: comparison of photon and proton techniques. Radiother Oncol. 2020;149:212-218.
Tamura M, Sakurai H, Mizumoto M, et al. Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients. J Radiat Res. 2017;58:363-371.
Pérez-Andújar A, Newhauser WD, DeLuca PM. Contribution to neutron fluence and neutron absorbed dose from double scattering proton therapy system components. Nucl Technol. 2009;168:728-735.
Mukherjee B, Lambert J, Hentschel R, Farr J. Explicit estimation of out-of-field neutron and gamma dose equivalents during proton therapy using thermoluminescence-dosimeters. Radiat Measur. 2011;46:1952-1955.
Clasie B, Wroe A, Kooy H, et al. Assessment of out-of-field absorbed dose and equivalent dose in proton fields. Med Phys. 2010;37:311-321.
Kry S, Bednarz B, Howell RM, et al. Report of the AAPM Task Group 158: Measurements and Calculations of Doses Outside the Treatment Volume from External Beam Radiation Therapy. College Park, MD: American Association of Physicists in Medicine; 2017.
Moyers MF, Benton ER, Ghebremedhin A, Coutrakon G. Leakage and scatter radiation from a double scattering based proton beamline. Med Phys. 2008;35:128-144.
Zheng Y, Liu Y, Zeidan O, Schreuder AN, Keole S. Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams. Med Phys. 2012;39:3484-3492.
Wang X, Sahoo N, Zhu RX, Zullo JR, Gillin MT. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system. Int J Radiat Oncol Biol Phys. 2010;76:1563-1570.
Mesoloras G, Sandison G, Stewart R, Farr J, Hsi W-C. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. Med Phys. 2006;7:2479-2490.
Wang X, Poenisch F, Sahoo N, et al. Spot scanning proton therapy minimizes neutron dose in the setting of radiation therapy administered during pregnancy. J Appl Clin Med Phys. 2016;17:366-376.
Miften M, Mihailidis D, Kry SF, et al. Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: a report of the AAPM TG-203†. Med Phys. 2019;46:e757-e788.
Moyers MF, Toth T, Sadagopan R, et al. Report of the AAPM Task Group 202: Physical Uncertainties in the Planning and Delivery of Light Ion Beam Treatments. College Park, MD: American Association of Physicists in Medicine; 2017.
Zhu XR, Poenisch F, Lii M, et al. Commissioning dose computation models for spot scanning proton beams in water for a commercially available treatment planning system. Med Phys. 2013;40:041723.
Pedroni E, Scheib S, Böhringer T, et al. Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams. Phys Med Biol. 2005;50:541-561.
Schaffner B. Proton dose calculation based on in-air fluence measurements. Phys Med Biol. 2008;53:1545-1562.
Sawakuchi GO, Titt U, Mirkovic D, et al. Monte Carlo investigation of the low-dose envelope from scanned proton pencil beams. Phys Med Biol. 2010;55:711-721.
Hong L, Goitein M, Bucciolini M, et al. A pencil beam algorithm for proton dose calculations. Phys Med Biol. 1996;41:1305-1330.
Szymanowski H, Mazal A, Nauraye C, et al. Experimental determination and verification of the parameters used in a proton pencil beam algorithm. Med Phys. 2001;28:975-987.
Sawakuchi GO, Titt U, Mirkovic D, Mohan R. Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams. Phys Med Biol. 2008;53:4605-4619.
Paganetti H, Jiang H, Parodi K, Slopsema R, Engelsman M. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy. Phys Med Biol. 2008;53:4825-4853.
Yamashita T, Akagi T, Aso T, Kimura A, Sasaki T. Effect of inhomogeneity in a patient's body on the accuracy of the pencil beam algorithm in comparison to Monte Carlo. Phys Med Biol. 2012;57:7673-7688.
Schuemann J, Giantsoudi D, Grassberger C, Moteabbed M, Min CH, Paganetti H. Assessing the clinical impact of approximations in analytical dose calculations for proton therapy. Int J Radiat Oncol Biol Phys. 2015;92:1157-1164.
Han Y. Current status of proton therapy techniques for lung cancer. Radiat Oncol J. 2019;37:232-248.
Widesott L, Lorentini S, Fracchiolla F, Farace P, Schwarz M. Improvements in pencil beam scanning proton therapy dose calculation accuracy in brain tumor cases with a commercial Monte Carlo algorithm. Phys Med Biol. 2018;63:145016.
Sorriaux J, Testa M, Paganetti H, et al. Experimental assessment of proton dose calculation accuracy in inhomogeneous media. Phys Med. 2017;38:10-15.
Lin L, Huang S, Kang M, et al. A benchmarking method to evaluate the accuracy of a commercial proton Monte Carlo pencil beam scanning treatment planning system. J Appl Clin Med Phys. 2017;18:44-49.
Inaniwa T, Kanematsu N, Hara Y, et al. Implementation of a triple Gaussian beam model with subdivision and redefinition against density heterogeneities in treatment planning for scanned carbon-ion radiotherapy. Phys Med Biol. 2014;59:5361-5386.
Clasie B, Depauw N, Fransen M, et al. Golden beam data for proton pencil-beam scanning. Phys Med Biol. 2012;57:1147-1158.
Kang M, Pang D. Commissioning and beam characterization of the first gantry-mounted accelerator pencil beam scanning proton system. Med Phys. 2019;47:3496-3510.
Anand A, Sahoo N, Zhu XR, et al. A procedure to determine the planar integral spot dose values of proton pencil beam spots. Med Phys. 2012;39:891-900.
Farr JB, Moskvin V, Lukose RC, Yao W, Schwamm F. Technical Note: design and characterization of a large diameter parallel plate ionization chamber for accurate integral depth dose measurements with proton beams. Med Phys. 2020;47:3214-3224.
Baumer C, Koska B, Lambert J, Timmermann B, Mertens T, Takoukam TP. Evaluation of detectors for acquisition of pristine depth-dose curves in pencil beam scanning. J Appl Clin Med Phys. 2015;16:151-163.
Fano U. Note on the Bragg-Gray cavity principle for measuring energy dissipation. Radiat Res. 1954;1:237-240.
Lin L, Ainsley CG, McDonough JE. Experimental characterization of two-dimensional pencil beam scanning proton spot profiles. Phys Med Biol. 2013;58:6193-6204.
Schwaab J, Brons S, Fieres J, Parodi K. Experimental characterization of lateral profiles of scanned proton and carbon ion pencil beams for improved beam models in ion therapy treatment planning. Phys Med Biol. 2011;56:7813-7827.
Braccini S, Ariga A, Ariga T, et al. Emulsion detectors for dose distribution characterization in the halo of proton pencil beams. Strahlenther Onkol. 2015;191:87.
Saini J, Cao N, Bowen S, et al. Clinical commissioning of a pencil beam scanning treatment planning system for proton therapy. Int J Particle Ther. 2016;3:51-60.
Nichiporov D, Hsi W, Farr J. Beam characteristics in two different proton uniform scanning systems: a side-by-side comparison. Med Phys. 2012;39:2559-2568.
Kramer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol. 2000;45:3299-3317.
Geng C, Moteabbed M, Xie Y, Schuemann J, Yock T, Paganetti H. Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning. Phys Med Biol. 2016;61:12-22.
Wang D, Smith BR, Gelover E, Flynn RT, Hyer DE. A method to select aperture margin in collimated spot scanning proton therapy. Phys Med Biol. 2015;60:N109-N119.
Yasui K, Toshito T, Omachi C, et al. A patient-specific aperture system with an energy absorber for spot scanning proton beams: verification for clinical application. Med Phys. 2015;42:6999-7010.
Baumer C, Fuentes C, Janson M, Matic A, Timmermann B, Wulff J. Stereotactical fields applied in proton spot scanning mode with range shifter and collimating aperture. Phys Med Biol. 2019;64:155003.
Gillin MT, Sahoo N, Bues M, et al. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys. 2010;37:154-163.
Sawakuchi GO, Mirkovic D, Perles LA, et al. An MCNPX Monte Carlo model of a discrete spot scanning proton beam therapy nozzle. Med Phys. 2010;37:4960-4970.
Tanaka H, Takata T, Ishi Y, et al. Development of proton beam irradiation system for small animals using FFAG accelerator. Nucl Instr Meth Phys Res A. 2019;922:230-234.
Iqbal K, Gillin M, Buzdar SA, Summers PA, Dhanesar S, Gifford KA. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom using. Br J Radiol. 2013;86:20130390.
Albertini F, Casiraghi M, Lorentini S, Rombi B, Lomax AJ. Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties. Phys Med Biol. 2011;56:4415-4431.